Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al. Reply

Basit Öğe Kaydı
dc.authorid0000-0003-1608-8820
dc.authorid0000-0003-0000-5568
dc.authorwosidCARRERA, CRISTINA/N-1887-2019
dc.authorwosidErfan, Gamze/W-8139-2018
dc.contributor.authorErfan, Gamze
dc.contributor.authorCarrera, Cristina
dc.contributor.authorMalvehy, Josep
dc.contributor.authorPuig, Susana
dc.date.accessioned2022-05-11T14:37:19Z
dc.date.available2022-05-11T14:37:19Z
dc.date.issued2017
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Deri ve Zührevi Hastalıkları Ana Bilim Dalı
dc.description.abstract[No Abstract Available]
dc.identifier.endpage1268
dc.identifier.issn0001-5555
dc.identifier.issn1651-2057
dc.identifier.issue10en_US
dc.identifier.startpage1267
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8656
dc.identifier.volume97
dc.identifier.wosWOS:000419735400028
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorErfan, Gamze
dc.language.isoen
dc.publisherActa Dermato-Venereologica
dc.relation.ispartofActa Dermato-Venereologica
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMetastatic Melanoma
dc.subjectMek Inhibitors
dc.subjectCombination
dc.subjectVemurafenib
dc.subjectToxicities
dc.subjectTherapy
dc.subjectManagement
dc.titleCutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al. Reply
dc.typeEditorial

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu